Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Phase II data on the effects and safety of REN-1654 in postherpetic neuralgia

March 15, 2005

Clinical candidate for depression, anxiety and ADHD presented at the ACS meeting

March 14, 2005

DNA testing may improve safety of Strattera

March 14, 2005

Seroquel findings reported at AAGP meeting

March 14, 2005

Sustained-release epidural morphine effective in reducing knee surgery pain

March 14, 2005

GSK discloses three series of Gly-T1 transporter inhibitors for schizophrenia

March 11, 2005

Novel cannabinoid receptor modulators prepared at the University of Tennessee

March 11, 2005

Yamanouchi may terminate PYM-50028 licensing agreement with Phytopharm

March 11, 2005

Labopharm seeks Mexican approval for once-daily tramadol

March 11, 2005

Studies reveal safety and treatment benefits of rasagiline in Parkinson's disease

March 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...